Why is HCTI trading below its narrow support or .02

Healthcare Triangle (HCTI) is trading below its narrow support level of $-0.02$ due to a combination of factors:

1. Technical Indicators Suggest Weakness: The stock's RSI is in oversold territory, indicating that it has been under significant selling pressure. This overselling can lead to a breakdown of support levels, as seen with HCTI's trading below $-0.02$.

2. Sector-Wide Weakness: Healthcare technology sector stocks are experiencing a decline, which is affecting HCTI's performance. This sector-wide weakness can lead to a drop in stock prices, even for companies that are not directly affected by the issues.
3. Company-Specific Challenges: HCTI has faced a significant decline in revenue, with a nearly 65% drop in the last twelve months. This decline in revenue, coupled with weak financial health indicators, has contributed to the stock's price struggles.
4. Market Sentiment and Volatility: The stock's price has been highly volatile, with a 12.12% drop on May 23, 2025, and a 14.29% drop on May 23, 2025. This volatility can lead to a breach of support levels as investors react to changing market conditions.
5. Lack of Positive Catalysts: Despite some strategic developments, such as new contracts and the expansion of AI-powered healthcare solutions, these positive factors have not yet translated into a rebound in the stock price.

In summary, HCTI's trading below its narrow support level is a result of a combination of technical indicators, sector-wide weakness, company-specific challenges, market sentiment, and the lack of positive catalysts. These factors have created a challenging environment for the stock, leading to its current low price.